“…Through ADME screening, 44 out of 150 components were selected from Zhishi, and most of them have ideal pharmacokinetic profiles. For example, hesperetin (ZS108, OB = 47.74%, Caco-2 = 0.28, DL = 0.27, GI = high) exhibits antioxidants (de Souza et al, 2016 ), anti-inflammatory(Choi and Lee, 2010 ), and vasoprotective (Kumar et al, 2013 ) actions; Similarly, naringenin (ZS115, OB = 59.29%, Caco-2 = 0.28, DL = 0.21, GI = high) has anti-inflammatory (Manchope et al, 2017 ), antibacterial (Wang L. H. et al, 2017 ), neuroprotective(Ramakrishnan et al, 2016 ) effects. It is worth noting that the value of Caco-2 in dihydroflavonosides of Zhishi is lower, such as narirutin (ZS144), naringin (ZS143), hesperidin (ZS130), and neohesperidin (ZS150), however, the four flavonoids were the main bioactive components in Zhishi and exhibited relatively high abundances (Liu et al, 2012 ), so these components were also preserved.…”